Last updated: July 17, 2026

Application No. 18/771,171

METHODS OF PERSONALIZING CANCER TREATMENT

Non-Final OA

Filed

Jul 12, 2024

Priority

Jul 13, 2023 — provisional 63/513,514

Examiner

WARD, PAUL V

Art Unit

Tech Center

Assignee

Processa Pharmaceuticals Inc.

OA Round

1 (Non-Final)

Interview Optional

— -11.5% interview lift. Interview lift (-11.5%) is below the 15.0% threshold. A written response is recommended.

Based on 1692 resolved cases, 2023–2026

Examiner Intelligence

WARD, PAUL V View full profile →

Grants 83% — above average

Career Allowance Rate

1408 granted / 1692 resolved

+23.2% vs TC avg

Minimal -12% lift

Without

With

+-11.5%

Interview Lift

resolved cases with interview

Typical timeline

2y 4m

Avg Prosecution

36 currently pending

Career history

1716

Total Applications

across all art units

Statute-Specific Performance

§101

0.7%

-39.3% vs TC avg

§103

29.6%

-10.4% vs TC avg

§102

8.5%

-31.5% vs TC avg

§112

42.9%

+2.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1692 resolved cases

Prosecution Timeline

Jul 12, 2024

Application Filed

Jun 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/011,836

Patent 12678384

SANITIZING COMPOSITIONS CONTAINING IONIC LIQUID

3y 6m to grant Granted Jul 14, 2026

18/128,362

Patent 12679810

METHOD FOR THE PREPARATION OF SULFINPYRAZONE

3y 3m to grant Granted Jul 14, 2026

17/913,760

Patent 12673057

RIPK2 INHIBITION FOR THE TREATMENT OF CANCER

3y 9m to grant Granted Jul 07, 2026

18/023,423

Patent 12661432

MULTIFUNCTIONAL, HYDROGEL HYBRID MATERIAL, THE METHOD OF ITS PREPARATION AND THE USE IN THE TREATMENT OF BONE LOSSES

3y 3m to grant Granted Jun 23, 2026

17/602,959

Patent 12655141

INHIBITORS OF NOTCH SIGNALING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS

4y 8m to grant Granted Jun 16, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

83%

Grant Probability

72%

With Interview (-11.5%)

2y 4m (~3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1692 resolved cases by this examiner. Grant probability derived from career allowance rate.